Pharmaceutical compositions comprising clofazimine analog compound B746 or clofazimine analog compound B826
AssigneeKamTek, Inc.
InventorsVenkata M. Reddy, Wolf Prensky, Sharanjit VedBrat
Life of this patent
Estimating the term…
Abstract
Methods for inhibiting the activity of Clostridium difficile in a subject comprise administering to the subject in need thereof a pharmaceutical composition comprising at least one pharmaceutically acceptable excipient and a clofazimine analog selected from B746 clofazimine analog or B826 clofazimine analog.
Claims9
A method for inhibiting the activity of Clostridium difficile in a subject, comprising administering to the subject in need thereof a pharmaceutical composition consisting of at least one pharmaceutically acceptable excipient and a compound selected from the group consisting of:
A method for inhibiting the activity of Clostridium difficile in a subject, comprising administering to the subject in need thereof a pharmaceutical composition consisting of at least one pharmaceutically acceptable excipient, at least one additional antimicrobial agent selected from the group consisting of azaquinone, metronidazole, vancomycin and fidaxomicin, and a compound selected from the group consisting of:
Dependencies are inferred from the claim text.